Clinical Trial Update: Topical Doxepin for Radiation-induced Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of topical doxepin to treat radiation-induced dermatitis in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxepin (topical) (doxepin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN